1. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy;Kopetz;J Clin Oncol,2009
2. Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts;Prewett;Clin Cancer Res,2002
3. Anti-epidermal growth factor receptor monotherapy in the treatment of metastatic colorectal cancer: where are we today?;Peeters;Oncologist,2009
4. FDA approval for cetuximab National Cancer Institute Web site http:www.cancer.govcancertopicsdruginfofda-cetuximab
5. FDA approval for panitumumab National Cancer Institute Web site http:www.cancer.govcancertopicsdruginfofda-panitumumab